Effect of sodium-glucose cotransporter-2 (SGLT2) inhibitors on serum urate levels in patients with and without diabetes: a systematic review and meta-regression of 43 randomized controlled trials

• Ngā kaituhi matua: Alicia Swee Yan Yip (Author), Shariel Leong (Author), Yao Hao Teo (Author), Yao Neng Teo (Author), Nicholas L. X. Syn (Author), Ray Meng See (Author), Caitlin Fern Wee (Author), Elliot Yeung Chong (Author), Chi-Hang Lee (Author), Mark Y. Chan (Author), Tiong-Cheng Yeo (Author), Raymond C. C. Wong (Author), Ping Chai (Author), Ching-Hui Sia (Author)
• Hōputu: Pukapuka
• I whakaputaina: SAGE Publishing, 2022-03-01T00:00:00Z.
• Ngā marau: article
• Urunga tuihono: Connect to this object online.

Objectives: Sodium-glucose cotransporter-2 (SGLT2) inhibitors have been found to reduce serum urate in patients with type 2 diabetes mellitus. To evaluate if this effect applies to both patients with and without diabetes, we conducted a systematic review and meta-analysis of SGLT2 inhibitors on seru...